TAYSHA GENE THERAPIES INC shareholders Q1 2023

TAYSHA GENE THERAPIES INC's ticker is TSHA and the CUSIP is 877619106. A total of 44 filers reported holding TAYSHA GENE THERAPIES INC in Q1 2023. The put-call ratio across all filers is 0.67 and the average weighting 0.0%.

TAYSHA GENE THERAPIES INC shareholders Q1 2023
NameSharesValueWeighting ↓
MILLENNIUM MANAGEMENT LLC 477,045$3800.00%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 16,140$12,8730.00%
MORGAN STANLEY 87,813$70,0390.00%
BlackRock Inc. 397,485$317,0340.00%
Tower Research Capital LLC (TRC) 7,255$60.00%
Citadel Advisors 1,200$9570.00%
Citadel Advisors 11,293$9,0070.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 100,044$79,7950.00%
SIMPLEX TRADING, LLC 10,767$80.00%
Citadel Advisors 1,800$1,4360.00%
JPMORGAN CHASE & CO 1,782$1,0000.00%
Renaissance Technologies 249,600$1990.00%
COMMONWEALTH EQUITY SERVICES, LLC 18,725$140.00%
ROYAL BANK OF CANADA 22$00.00%
Allworth Financial LP 1,000$7980.00%
VANGUARD GROUP INC 1,583,438$1,262,9500.00%
UBS Group AG 3,550$2,8330.00%
Engineers Gate Manager LP 13,650$10,8870.00%
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 10,000$7,9760.00%
Kovitz Investment Group Partners, LLC 15,000$120.00%
External links

This page lists TAYSHA GENE THERAPIES INC's shareholders in Q1 2023. To view TAYSHA GENE THERAPIES INC's shareholder history, click here.